BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37802293)

  • 1. GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted Therapeutics.
    Zecchin D; Knöpfel N; Gluck AK; Stevenson M; Sauvadet A; Polubothu S; Barberan-Martin S; Michailidis F; Bryant D; Inoue A; Lines KE; Hannan FM; Semple RK; Thakker RV; Kinsler VA
    J Invest Dermatol; 2024 Apr; 144(4):811-819.e4. PubMed ID: 37802293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
    Knöpfel N; Zecchin D; Richardson H; Polubothu S; Barberan-Martin S; Cullup T; Gholam K; Heales S; Krywawych S; López-Balboa P; Muwanga-Nanyonjo N; Ogunbiyi O; Puvirajasinghe C; Solman L; Swarbrick K; Syed SB; Tahir Z; Tisdall MM; Allgrove J; Chesover AD; Aylett SE; Jacques TS; Hannan FM; Löbel U; Semple RK; Thakker RV; Kinsler VA
    J Invest Dermatol; 2024 Apr; 144(4):820-832.e9. PubMed ID: 37802294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome.
    Huang L; Couto JA; Pinto A; Alexandrescu S; Madsen JR; Greene AK; Sahin M; Bischoff J
    Pediatr Neurol; 2017 Feb; 67():59-63. PubMed ID: 27919468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11.
    Davies OMT; Ng AT; Tran J; Blumenthal S; Arkin LM; Nopper AJ; Cottrell CE; Garzon M; Siegel DH; Frieden IJ; Drolet BA
    Pediatr Dermatol; 2022 Nov; 39(6):914-919. PubMed ID: 36440997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.
    Ayturk UM; Couto JA; Hann S; Mulliken JB; Williams KL; Huang AY; Fishman SJ; Boyd TK; Kozakewich HP; Bischoff J; Greene AK; Warman ML
    Am J Hum Genet; 2016 Apr; 98(4):789-95. PubMed ID: 27058448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation.
    Jordan M; Carmignac V; Sorlin A; Kuentz P; Albuisson J; Borradori L; Bourrat E; Boute O; Bukvic N; Bursztejn AC; Chiaverini C; Delobel B; Fournet M; Martel J; Goldenberg A; Hadj-Rabia S; Mahé A; Maruani A; Mazereeuw J; Mignot C; Morice-Picard F; Moutard ML; Petit F; Pasteur J; Phan A; Whalen S; Willems M; Philippe C; Vabres P
    J Invest Dermatol; 2020 May; 140(5):1106-1110.e2. PubMed ID: 31726051
    [No Abstract]   [Full Text] [Related]  

  • 9. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
    Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
    Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.
    Liau JY; Tsai JH; Lan J; Chen CC; Wang YH; Lee JC; Huang HY
    Virchows Arch; 2020 Mar; 476(3):475-481. PubMed ID: 31707589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.
    Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC
    Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
    Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
    Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAQ and GNA11 mutations in uveal melanoma.
    Shoushtari AN; Carvajal RD
    Melanoma Res; 2014 Dec; 24(6):525-34. PubMed ID: 25304237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.
    Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
    Shirley MD; Tang H; Gallione CJ; Baugher JD; Frelin LP; Cohen B; North PE; Marchuk DA; Comi AM; Pevsner J
    N Engl J Med; 2013 May; 368(21):1971-9. PubMed ID: 23656586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
    Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
    Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Patient-Derived GNAQ Mutated Endothelial Cells from Capillary Malformations.
    Langbroek GB; Stor MLE; Janssen V; de Haan A; Horbach SER; Graupera M; van Noesel CJM; van der Horst CMAM; Wolkerstorfer A; Huveneers S
    J Invest Dermatol; 2024 Jun; 144(6):1378-1388.e1. PubMed ID: 38013159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.